Wellington Management Group Portfolio holdings
Wellington Management Group, founded in 1928 by Walter L. Morgan and headquartered in Boston, Massachusetts, is one of the world’s largest independent asset management firms, overseeing trillions in assets for a diverse client base including pension funds, endowments, and mutual fund investors. Renowned for its active management approach, Wellington offers a broad range of investment strategies across equities, fixed income, multi-asset, and alternative investments, emphasizing deep research and long-term partnerships with clients. The firm gained early fame for launching the Wellington Fund, one of the first balanced mutual funds, and has since maintained a reputation for disciplined, collaborative portfolio management. With a global presence and a focus on customized solutions, Wellington remains a trusted name in institutional and retail investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.67B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.58B |
| 3 |
TE Connectivity
TEL
|
+$948M |
| 4 |
Tesla
TSLA
|
+$910M |
| 5 |
Boeing
BA
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
General Dynamics
GD
|
+$1.7B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Visa
V
|
+$1.5B |
| 4 |
Morgan Stanley
MS
|
+$1.27B |
| 5 |
Exelon
EXC
|
+$1.19B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Healthcare | 17.88% |
| 3 | Financials | 14.68% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
PUT
iShares MSCI Brazil ETF
EWZ
$9.23B
| $1.91M | ﹤0.01% |
+41,531
| New | +$1.11M |
|
1502
GE HealthCare
GEHC
$32B
| $1.9M | ﹤0.01% |
24,341
+3,575
| +17% | +$304K |
|
1503
Corcept Therapeutics
CORT
$12B
| $1.9M | ﹤0.01% |
37,719
-3,347
| -8% | -$175K |
|
1504
Citizens Community Bancorp
CZWI
$212M
| $1.9M | ﹤0.01% |
116,644
| – | – |
|
1505
Mesa Laboratories
MLAB
$573M
| $1.89M | ﹤0.01% |
+14,314
| New | +$1.76M |
|
1506
Fortis
FTS
$28.8B
| $1.89M | ﹤0.01% |
45,431
+1,577
| +4% | +$69K |
|
1507
Theravance Biopharma
TBPH
$875M
| $1.87M | ﹤0.01% |
198,491
+7,162
| +4% | +$65.2K |
|
|
MZTI
1508
The Marzetti Company
MZTI
$3.01B
| $1.86M | ﹤0.01% |
10,771
-72,859
| -87% | -$13.3M |
|
|
ORKA
1509
Oruka Therapeutics
ORKA
$5.92B
| $1.84M | ﹤0.01% |
95,089
+12,952
| +16% | +$316K |
|
1510
Krystal Biotech
KRYS
$9.44B
| $1.83M | ﹤0.01% |
11,704
-976
| -8% | -$173K |
|
1511
Teradyne
TER
$61.8B
| $1.83M | ﹤0.01% |
14,554
+3,870
| +36% | +$458K |
|
1512
Enliven Therapeutics
ELVN
$4.25B
| $1.82M | ﹤0.01% |
80,916
+10,746
| +15% | +$279K |
|
1513
ADMA Biologics
ADMA
$2.09B
| $1.81M | ﹤0.01% |
105,459
-13,834
| -12% | -$260K |
|
1514
Nuvation Bio
NUVB
$2.26B
| $1.8M | ﹤0.01% |
676,024
+52,051
| +8% | +$134K |
|
1515
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.1B
| $1.8M | ﹤0.01% |
11,112
| – | – |
|
1516
Evolus
EOLS
$405M
| $1.79M | ﹤0.01% |
162,239
-12,800
| -7% | -$180K |
|
1517
Ulta Beauty
ULTA
$23.5B
| $1.79M | ﹤0.01% |
4,111
-1,524
| -27% | -$590K |
|
1518
Teck Resources
TECK
$32.4B
| $1.78M | ﹤0.01% |
43,897
-60,404
| -58% | -$2.82M |
|
1519
BridgeBio Pharma
BBIO
$16.2B
| $1.78M | ﹤0.01% |
64,807
-4,779
| -7% | -$124K |
|
1520
HF Sinclair
DINO
$15.3B
| $1.77M | ﹤0.01% |
50,482
+41,430
| +458% | +$1.69M |
|
1521
Prestige Consumer Healthcare
PBH
$2.48B
| $1.77M | ﹤0.01% |
22,604
-65,354
| -74% | -$5.07M |
|
1522
ManpowerGroup
MAN
$2.51B
| $1.76M | ﹤0.01% |
30,576
-969,624
| -97% | -$61.8M |
|
1523
Illinois Tool Works
ITW
$85.1B
| $1.76M | ﹤0.01% |
6,937
-10,034
| -59% | -$2.66M |
|
|
BRKL
1524
DELISTED
Brookline Bancorp
BRKL
| $1.75M | ﹤0.01% |
147,998
| – | – |
|
1525
Fidelity National Information Services
FIS
$22.3B
| $1.74M | ﹤0.01% |
21,587
+4,180
| +24% | +$360K |
|
Similar funds
Wellington Management Group's Q4 2024 Portfolio in Review
As of Q4 2024, Wellington Management Group held 2,066 positions worth $546B, down 4.3% from $571B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Wellington Management Group withdrew a net $25.7B in Q4 2024, closing 139 positions and reducing 894 holdings. Its most notable exit was Lineage Inc, an estimated $266M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Wellington Management Group opened a new position in TE Connectivity worth $910M.
- Wellington Management Group's largest Q4 2024 buy was TE Connectivity: 6,362,160 shares worth $910M.
- Wellington Management Group added most to Eli Lilly in Q4 2024, an estimated $1.67B increase.
- Wellington Management Group's biggest Q4 2024 reduction was General Dynamics, cutting an estimated $1.7B.
- Wellington Management Group fully exited Lineage Inc in Q4 2024, selling an estimated $266M.
- Wellington Management Group's ten largest holdings make up 25% of its $546B portfolio in Q4 2024.
- Wellington Management Group opened 161 new positions and closed 139 in Q4 2024.
- Wellington Management Group's portfolio value fell 4.3% quarter-over-quarter to $546B.
Based on Wellington Management Group's 13F filing for Q4 2024, filed 12 Feb 2025.